INM Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,091 | H-ExpireLong | D | 61 | 927.64 | 56,586.04 |
| 2023-03-08 | ADAMS ERIC A | director, officer: President & CEO | 27,957 | H-ExpireLong | D | 545 | 927.64 | 505,563.80 |
| 2023-03-08 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,333 | H-ExpireLong | D | 545 | 927.64 | 505,563.80 |
| 2022-12-16 | Lemerond Nicole | director | 1,400 | A-Award | A | 840 | 1.78 | 1,495.20 |
| 2022-12-16 | Tegge Jonathan | officer: Interim CFO | 1,400 | A-Award | A | 1,400 | 1.78 | 2,492.00 |
| 2022-12-16 | Li Sarah | officer: VP Accounting & Controller | 4,002 | A-Award | A | 3,600 | 1.78 | 6,408.00 |
| 2022-12-16 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 11,342 | A-Award | A | 7,500 | 1.78 | 13,350.00 |
| 2022-12-16 | Johnson Shane Aaron | officer: Sr VP & General Manager | 8,000 | A-Award | A | 4,200 | 1.78 | 7,476.00 |
| 2022-12-16 | Grove Janet P | director | 1,400 | A-Award | A | 840 | 1.78 | 1,495.20 |
| 2022-12-16 | HULL ANDREW | director | 1,484 | A-Award | A | 840 | 1.78 | 1,495.20 |
| 2022-12-16 | Baldasare Bryan T | director | 1,400 | A-Award | A | 840 | 1.78 | 1,495.20 |
| 2022-12-16 | ADAMS ERIC A | director, officer: President & CEO | 28,502 | A-Award | A | 15,000 | 1.78 | 26,700.00 |
| 2022-12-16 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,878 | A-Award | A | 4,200 | 1.78 | 7,476.00 |
| 2022-12-16 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,152 | A-Award | A | 4,200 | 1.78 | 7,476.00 |
| 2022-11-14 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 3,842 | D-Return | D | 7,500 | 2.78 | 20,850.00 |
| 2022-11-14 | ADAMS ERIC A | director, officer: President & CEO | 13,502 | D-Return | D | 15,000 | 2.78 | 41,700.00 |
| 2022-11-14 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 4,678 | D-Return | D | 4,200 | 2.78 | 11,676.00 |
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 3,952 | D-Return | D | 4,200 | 2.78 | 11,676.00 |
| 2022-11-14 | Johnson Shane Aaron | officer: Sr VP & General Manager | 3,800 | D-Return | D | 4,200 | 2.78 | 11,676.00 |
| 2022-11-14 | Johnson Shane Aaron | officer: Sr. VP & General Manager | 8,000 | A-Award | A | 4,200 | 2.78 | 11,676.00 |
| 2022-11-14 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,878 | A-Award | A | 4,200 | 2.78 | 11,676.00 |
| 2022-11-14 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 11,342 | A-Award | A | 7,500 | 2.78 | 20,850.00 |
| 2022-11-14 | ADAMS ERIC A | director, officer: President & CEO | 28,502 | A-Award | A | 15,000 | 2.78 | 41,700.00 |
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,152 | A-Award | A | 4,200 | 2.78 | 11,676.00 |
| 2022-08-10 | Lemerond Nicole | director | 14,000 | A-Award | A | 14,000 | 0.39 | 5,460.00 |
| 2022-06-02 | ADAMS ERIC A | director, officer: President & CEO | 337,576 | H-ExpireLong | D | 13,636 | 11.75 | 160,223.00 |
| 2022-06-02 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 98,787 | H-ExpireLong | D | 1,515 | 11.75 | 17,801.25 |
| 2022-05-17 | Baldasare Bryan T | director | 14,000 | A-Award | D | 14,000 | 0.80 | 11,200.00 |
| 2022-04-14 | ADAMS ERIC A | director, officer: President & CEO | 59,003 | P-Purchase | A | 14,160 | 0.89 | 12,659.04 |
| 2022-04-13 | ADAMS ERIC A | director, officer: President & CEO | 44,843 | P-Purchase | A | 8,560 | 0.85 | 7,276.00 |
| 2022-02-23 | WOUDENBERG MICHAEL | officer: SVP, Chem/Manufacturing/Control | 96,060 | A-Award | A | 5,000 | 1.01 | 5,050.00 |
| 2022-02-20 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 100,302 | H-ExpireLong | D | 3,030 | 9.59 | 29,057.70 |
| 2022-02-18 | Grove Janet P | director | 14,000 | A-Award | A | 14,000 | 1.12 | 15,680.00 |
| 2022-01-24 | Cutler Adam D. | director | 16,122 | H-ExpireLong | D | 22,727 | 2.89 | 65,681.03 |
| 2022-01-24 | Cutler Adam D. | director | 38,849 | H-ExpireLong | D | 1,515 | 3.68 | 5,575.20 |
| 2022-01-24 | Cutler Adam D. | director | 40,364 | H-ExpireLong | D | 6,061 | 3.82 | 23,153.02 |
| 2022-01-24 | HULL ANDREW | director | 16,122 | H-ExpireLong | D | 30,303 | 2.89 | 87,575.67 |
| 2022-01-24 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 103,332 | H-ExpireLong | D | 12,121 | 5.13 | 62,180.73 |
| 2022-01-24 | ADAMS ERIC A | director, officer: President & CEO | 351,212 | H-ExpireLong | D | 60,606 | 2.89 | 175,151.34 |
| 2022-01-24 | ADAMS ERIC A | director, officer: President & CEO | 411,818 | H-ExpireLong | D | 60,606 | 2.10 | 127,272.60 |
| 2022-01-24 | Garner William J | director | 16,122 | H-ExpireLong | D | 24,242 | 3.42 | 82,907.64 |
| 2022-01-24 | COLWILL BRUCE | officer: CFO | 11,515 | P-Purchase | A | 5,000 | 1.09 | 5,438.50 |
| 2022-01-06 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 304,595 | P-Purchase | A | 8,500 | 1.26 | 10,710.00 |
| 2021-12-30 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 296,095 | P-Purchase | A | 8,093 | 1.33 | 10,736.17 |
| 2021-12-29 | Sazdanoff Catherine | director | 29,091 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | Cutler Adam D. | director | 46,425 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | Garner William J | director | 40,364 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | HULL ANDREW | director | 46,425 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-11-15 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 288,002 | P-Purchase | A | 5,000 | 1.37 | 6,845.00 |
| 2021-10-18 | WOUDENBERG MICHAEL | officer: VP, Chem/Manufacturing/Control | 91,060 | A-Award | A | 30,000 | 1.40 | 42,000.00 |
| 2021-10-18 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 116,969 | A-Award | A | 35,000 | 1.40 | 49,000.00 |
| 2021-10-18 | ADAMS ERIC A | director, officer: President & CEO | 472,424 | A-Award | A | 125,000 | 1.40 | 175,000.00 |
| 2021-10-18 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 115,453 | A-Award | A | 35,000 | 1.40 | 49,000.00 |
| 2021-10-18 | COLWILL BRUCE | officer: CFO | 150,303 | A-Award | A | 60,000 | 1.40 | 84,000.00 |
| 2021-09-29 | ADAMS ERIC A | director, officer: President & CEO | 36,283 | P-Purchase | A | 8,800 | 1.73 | 15,224.00 |
| 2021-09-28 | COLWILL BRUCE | officer: CFO | 6,515 | P-Purchase | A | 5,000 | 1.77 | 8,840.00 |
| 2021-09-28 | ADAMS ERIC A | director, officer: President & CEO | 27,483 | P-Purchase | A | 11,400 | 1.75 | 19,984.20 |
| 2020-12-16 | WOUDENBERG MICHAEL | officer: VP, Chem/Manufacturing/Control | 30,000 | A-Award | A | 30,000 | 3.02 | 90,600.00 |
| 2020-12-16 | Sazdanoff Catherine | director | 11,000 | A-Award | A | 11,000 | 3.02 | 33,220.00 |
| 2020-12-16 | Sazdanoff Catherine | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | Cutler Adam D. | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | HULL ANDREW | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 35,000 | A-Award | A | 35,000 | 3.02 | 105,700.00 |
| 2020-12-16 | ADAMS ERIC A | director, officer: President & CEO | 125,000 | A-Award | A | 125,000 | 3.02 | 377,500.00 |
| 2020-12-16 | Garner William J | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 35,000 | A-Award | A | 35,000 | 3.02 | 105,700.00 |
| 2020-12-16 | COLWILL BRUCE | officer: CFO | 60,000 | A-Award | A | 60,000 | 3.02 | 181,200.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.